STOCK TITAN

Absci (NASDAQ: ABSI) CFO receives new RSU and stock option awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4/A

Rhea-AI Filing Summary

Absci Corp CFO/CBO Zachariah Jonasson reported routine equity compensation and related tax withholding. On March 2, 2026, he received awards of 135,400 shares of Common Stock as restricted stock units and stock options for 534,400 shares of Common Stock with a $2.80 exercise price, vesting in three equal annual installments starting March 1, 2027.

On March 3, 2026, 10,848 shares of Common Stock were withheld at $2.80 per share to cover tax obligations from RSU vesting, which the company states was not a discretionary trade. After these transactions, he directly owns 499,783 Common Stock shares and holds 534,400 stock options.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Jonasson Zachariah

(Last) (First) (Middle)
C/O ABSCI CORPORATION
18105 SE MILL PLAIN BLVD

(Street)
VANCOUVER WA 98683

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Absci Corp [ ABSI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CFO / CBO
3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
03/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/02/2026 A 135,400(1) A $0 510,631 D
Common Stock 03/03/2026 F 10,848(2) D $2.8 499,783 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $2.8 03/02/2026 A 534,400(3) (3) 03/01/2036 Common Stock 534,400 $0 534,400 D
Explanation of Responses:
1. The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. The RSUs shall vest and be settled in three substantially equal annual installments with the first such annual installment vesting on March 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date.
2. Amount reported represents the number of shares withheld by the Issuer to cover the tax withholding obligation in connection with the vesting of these restricted stock units and does not represent a discretionary trade by the reporting person.
3. The shares subject to this option shall vest and become exercisable over a three year period, in substantially equal annual installments with the first such installment vesting on March 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date.
Remarks:
This Form 4/A amends the Form 4 filed on March 4, 2026 to correct the expiration date of the option previously reported. The original filing inadvertently reported the expiration date as February 29, 2036. The expiration date is hereby corrected to reflect March 1, 2036. The reported transaction was exempt pursuant to Rule 16b-3 under the Securities Exchange Act of 1934. The Form 4 is otherwise unchanged.
/s/ Shelby Walker, attorney-in-fact 03/16/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Absci (ABSI) CFO Zachariah Jonasson receive?

He received 135,400 restricted stock units and stock options for 534,400 shares of Common Stock at a $2.80 exercise price. Both awards vest in three substantially equal annual installments beginning on March 1, 2027, subject to continuous service.

How do the new Absci (ABSI) RSUs to the CFO vest and settle?

The restricted stock units vest and are settled in three substantially equal annual installments starting on March 1, 2027. Each installment requires the CFO to remain in continuous service with Absci on the applicable vesting date under the 2021 Stock Option and Incentive Plan.

What are the terms of the new Absci (ABSI) stock options granted to the CFO?

The stock options cover 534,400 shares of Common Stock at a $2.80 exercise price and expire on March 1, 2036. They vest over three years in substantially equal annual installments beginning on March 1, 2027, contingent on continued service.

Why were 10,848 Absci (ABSI) shares disposed of in this Form 4/A?

The 10,848 shares were withheld by Absci to cover tax withholding obligations related to RSU vesting at $2.80 per share. The filing states this withholding was not a discretionary trade by the reporting person but a tax payment mechanism.

How many Absci (ABSI) shares does the CFO hold after these transactions?

Following the reported transactions, the CFO directly holds 499,783 shares of Absci Common Stock. In addition, he holds stock options for 534,400 underlying shares, which vest over three years starting in 2027, subject to continued service.

Does the Absci (ABSI) Form 4/A show any open-market buying or selling by the CFO?

No open-market purchases or sales are reported. The filing shows equity compensation grants and shares withheld for taxes. The tax-withholding disposition is specifically described as not a discretionary trade by the reporting person, reflecting routine compensation-related activity.
Absci Corp

NASDAQ:ABSI

View ABSI Stock Overview

ABSI Rankings

ABSI Latest News

ABSI Latest SEC Filings

ABSI Stock Data

439.08M
128.99M
Biotechnology
Services-commercial Physical & Biological Research
Link
United States
VANCOUVER